Cannell Capital GRACELL BIOTECHNOLOGIES INC ownership

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 34 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Cannell Capital ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2022$32,888
+71395.7%
14,2990.0%0.01%
-36.4%
Q3 2022$46
+283.3%
14,299
+553.2%
0.01%
+450.0%
Q2 2022$122,1890.00%